CoChat

Intensity of Anticoagulation To Prevent Stroke in Patients with Atrial Fibrillation

Hart, Robert G. · 1998 · Annals of Internal Medicine
Cited by 42

The DOI matches its Crossref record.

Abstract

Letters1 March 1998Intensity of Anticoagulation To Prevent Stroke in Patients with Atrial FibrillationRobert G. Hart, MDRobert G. Hart, MDUniversity of Texas Health Science Center; San Antonio, TX 78284Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-128-5-199803010-00012 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:In their "Update in General Internal Medicine," Sheffield and Larson [1] cite the conclusions of a case–control study [2] reporting that the lowest effective intensity of warfarin for atrial fibrillation is an international normalized ratio (INR) of 2.0. This is an oversimplification of available information.In the case–control study by Hylek and colleagues [2], INRs of 2.0 or more seemed to provide optimal protection against stroke. However, INRs between 1.6 and 1.9 were associated with an 80% or greater reduction in risk for stroke compared with INRs of 1.0 to 1.1 (equivalent to untreated patients). This partial ...References1. Sheffield JV, Larson EB. Update in general internal medicine. Ann Intern Med. 1997; 127:43-51. Google Scholar2. Hylek EM, Skates SJ, Sheehan MA, Singer DE. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med. 1996; 335:540-6. Google Scholar3. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: stroke prevention in atrial fibrillation III randomized clinical trial. Stroke Prevention in Atrial Fibrillation Investigators. Lancet. 1996; 348:633-8. Google Scholar4. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med. 1992; 327:1406-12. Google Scholar5. The effect of low-dose warfarin on the risk of stroke in non-rheumatic atrial fibrillation. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. N Engl J Med. 1990; 323:1505-11. Google Scholar Author, Article, and Disclosure InformationAuthors: Robert G. Hart, MDAffiliations: University of Texas Health Science Center; San Antonio, TX 78284 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byIndonesian registry on atrial fibrillation (OneAF)Evidence-Based Management of Anticoagulant TherapyVascular DementiaHeart Disease and Stroke Statistics—2011 UpdateSecondary Prevention of Cardioembolic StrokeHeart Disease and Stroke Statistics—2010 UpdateHeart Disease and Stroke Statistics—2009 UpdateRisk Factor Management to Prevent First StrokeMeta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial FibrillationRobert G. Hart, MD, Lesly A. Pearce, MS, and Maria I. Aguilar, MDPrimary Prevention of Ischemic StrokeAtrial fibrillation and stroke: Four treatment controversiesAntiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacksPeople Aged Over 75 in Atrial Fibrillation on Warfarin: The Rate of Major Hemorrhage and Stroke in More Than 500 Patient-Years of Follow-UpSecondary Prevention of Cardioembolic StrokeAtrial Fibrillation in the Elderly: Anticoagulation Strategies and Indications in the Very ElderlyNeurologic Manifestations of Cardiogenic EmbolismACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and ElectrophysiologyACC/AHA/ESC guidelines for the management of patients with atrial fibrillation31This document was approved by the American College of Cardiology Board of Trustees in August 2001, the American Heart Association Science Advisory and Coordinating Committee in August 2001, and the European Society of Cardiology Board and Committee for Practice Guidelines and Policy Conferences in August 2001.32When citing this document, the American College of Cardiology, the American Heart Association, and the European Society of Cardiology would appreciate the following citation format: Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Lévy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Dev

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/0003-4819-128-5-199803010-00012

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 42

Metadata

Authors
Hart, R. G.
Venue
Annals of Internal Medicine
Published
1998-03-01
Volume
128
Issue
5
Pages
408
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2012264788
Cited by
42
References
0
FWCI
5.69
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intensity of Anticoagulation To Prevent Stroke in Patients with Atrial Fibrillation. https://app.cochat.ai/papers/10.7326/0003-4819-128-5-199803010-00012
The paper
Hart, R. G. (1998). Intensity of Anticoagulation To Prevent Stroke in Patients with Atrial Fibrillation. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-128-5-199803010-00012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.